Ki67 proliferation index as a tool for chemotherapy decisions during and after neoadjuvant aromatase inhibitor treatment of breast cancer: results from the American …

MJ Ellis, VJ Suman, J Hoog, R Goncalves… - Journal of Clinical …, 2017 - ascopubs.org
Purpose To determine the pathologic complete response (pCR) rate in estrogen receptor
(ER)–positive primary breast cancer triaged to chemotherapy when the protein encoded by …
被引用次数：327 相关文章

Ki67 proliferation index as a tool for chemotherapy decisions during and after neoadjuvant aromatase inhibitor treatment of breast cancer: Results from the American …

MJ Ellis, VJ Suman, J Hoog… - Journal of …, 2017 - mdanderson.elsevierpure.com
Purpose To determine the pathologic complete response (PCR) rate in estrogen receptor
(ER)-positive primary breast cancer triaged to chemotherapy when the protein encoded by …

Ki67 proliferation index as a tool for chemotherapy decisions during and after neoadjuvant aromatase inhibitor treatment of breast cancer: Results from the American …

MJ Ellis, VJ Suman, J Hoog… - Journal of …, 2017 - utsouthwestern.elsevierpure.com
Purpose To determine the pathologic complete response (PCR) rate in estrogen receptor
(ER)-positive primary breast cancer triaged to chemotherapy when the protein encoded by …
[HTML] nih.gov

[HTML][HTML] Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From …

MJ Ellis, VJ Suman, J Hoog, R Goncalves… - Journal of Clinical …, 2017 - ncbi.nlm.nih.gov
Purpose To determine the pathologic complete response (pCR) rate in estrogen receptor
(ER)–positive primary breast cancer triaged to chemotherapy when the protein encoded by …
[PDF] core.ac.uk

[PDF][PDF] Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the …

MJ Ellis, VJ Suman, J Hoog, R Goncalves, S Sanati… - J Clin Oncol, 2017 - core.ac.uk
Purpose To determine the pathologic complete response (pCR) rate in estrogen receptor
(ER)–positive primary breast cancer triaged to chemotherapy when the protein encoded by …

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the …

MJ Ellis, VJ Suman, J Hoog, R Goncalves… - Journal of Clinical …, 2017 - europepmc.org
Purpose To determine the pathologic complete response (pCR) rate in estrogen receptor
(ER)-positive primary breast cancer triaged to chemotherapy when the protein encoded by …

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the …

MJ Ellis, VJ Suman, J Hoog, R Goncalves… - Journal of Clinical …, 2017 - cir.nii.ac.jp
< jats: sec>< jats: title> Purpose</jats: title>< jats: p> To determine the pathologic complete
response (pCR) rate in estrogen receptor (ER)–positive primary breast cancer triaged to …
[PDF] semanticscholar.org

[PDF][PDF] Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the …

MJ Ellis, VJ Suman, J Hoog, R Goncalves, S Sanati… - 2017 - pdfs.semanticscholar.org
Purpose To determine the pathologic complete response (pCR) rate in estrogen receptor
(ER)–positive primary breast cancer triaged to chemotherapy when the protein encoded by …

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the …

MJ Ellis, VJ Suman, J Hoog… - Journal of clinical …, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose To determine the pathologic complete response (pCR) rate in estrogen receptor
(ER)-positive primary breast cancer triaged to chemotherapy when the protein encoded by …
[PDF] academia.edu

[PDF][PDF] Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the …

MJ Ellis, VJ Suman, J Hoog, R Goncalves, S Sanati… - 2017 - academia.edu
Purpose To determine the pathologic complete response (pCR) rate in estrogen receptor
(ER)–positive primary breast cancer triaged to chemotherapy when the protein encoded by …